deoxycytidine has been researched along with Hemorrhagic Fever, Ebola in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deval, J; Fearns, R | 1 |
| Albariño, CG; Bluemling, GR; Chakrabarti, AK; Flint, M; Guerrero, LW; McMullan, LK; Nichol, ST; Painter, GR; Spiropoulou, CF; Welch, SR | 1 |
1 review(s) available for deoxycytidine and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
Topics: Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; DNA-Directed RNA Polymerases; Hemorrhagic Fever, Ebola; Humans; Measles; Mononegavirales; Nucleosides; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; RNA-Dependent RNA Polymerase; RNA, Messenger; Transcription, Genetic; Virus Replication | 2016 |
1 other study(ies) available for deoxycytidine and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
Topics: Antiviral Agents; Azauridine; Deoxycytidine; Drug Discovery; Ebolavirus; Genes, Reporter; Genome, Viral; Green Fluorescent Proteins; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Lassa Fever; Lassa virus; Luciferases | 2016 |